{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arthritis%2C+Rheumatoid%3B+Arthritis%2C+Psoriatic&page=2", "query": { "condition": "Arthritis, Rheumatoid; Arthritis, Psoriatic", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arthritis%2C+Rheumatoid%3B+Arthritis%2C+Psoriatic&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-11T10:39:40.533Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05715463", "title": "Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rheumatoid Arthritis", "Palindromic Arthritis", "Juvenile Rheumatoid Arthritis", "Ankylosing Spondylitis", "Sacroiliitis", "Psoriatic Arthritis", "Mixed Connective Tissue Disease", "Lupus", "Enteropathic Arthropathies", "Systemic Sclerosis", "Sjogren's Syndrome", "Sicca Syndrome", "Inflammatory Arthritis", "Undifferentiated Connective Tissue Diseases" ], "interventions": [ { "name": "Resource sheets", "type": "OTHER" }, { "name": "Community Resource Specialist", "type": "OTHER" }, { "name": "Nurse Navigator", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 101, "start_date": "2023-03-01", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2025-10-15", "last_synced_at": "2026-06-11T10:39:40.533Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05715463" }, { "nct_id": "NCT02418442", "title": "Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatic Joint Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 20000, "start_date": "2015-07", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2025-10-14", "last_synced_at": "2026-06-11T10:39:40.533Z", "location_count": 75, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02418442" }, { "nct_id": "NCT07138898", "title": "Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatic Disease" ], "interventions": [ { "name": "Methotrexate", "type": "DRUG" }, { "name": "Sulfasalazine", "type": "DRUG" }, { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Leflunomide", "type": "DRUG" }, { "name": "Azathioprine", "type": "DRUG" }, { "name": "Mycophenolate", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Etanercept", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Golimumab", "type": "DRUG" }, { "name": "Certolizumab", "type": "DRUG" }, { "name": "Infliximab", "type": "DRUG" }, { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Belimumab", "type": "BIOLOGICAL" }, { "name": "Tocilizumab", "type": "BIOLOGICAL" }, { "name": "Anakinra", "type": "BIOLOGICAL" }, { "name": "Canakinumab", "type": "BIOLOGICAL" }, { "name": "Abatacept", "type": "BIOLOGICAL" }, { "name": "Secukinumab", "type": "BIOLOGICAL" }, { "name": "Ixekizumab", "type": "BIOLOGICAL" }, { "name": "Bimekizumab", "type": "BIOLOGICAL" }, { "name": "Ustekinumab", "type": "BIOLOGICAL" }, { "name": "Guselkumab", "type": "BIOLOGICAL" }, { "name": "Risankizumab", "type": "BIOLOGICAL" }, { "name": "Tofacitinib", "type": "DRUG" }, { "name": "Upadacitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2025-09", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2025-08-24", "last_synced_at": "2026-06-11T10:39:40.533Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07138898" }, { "nct_id": "NCT05421442", "title": "A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis (RA)", "Psoriatic Arthritis (PsA)" ], "interventions": [], "intervention_types": [], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 38396, "start_date": "2019-06-13", "completion_date": "2025-10-31", "has_results": false, "last_update_posted_date": "2025-12-08", "last_synced_at": "2026-06-11T10:39:40.533Z", "location_count": 1, "location_summary": "Lawrenceville, New Jersey", "locations": [ { "city": "Lawrenceville", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05421442" }, { "nct_id": "NCT06555562", "title": "Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Psoriatic Arthritis", "Rheumatoid Arthritis", "Ankylosing Spondylitis" ], "interventions": [ { "name": "Ultrasound Stimulation", "type": "DEVICE" }, { "name": "Non-active ultrasound stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Surf Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "22 Years to 75 Years" }, "enrollment_count": 16, "start_date": "2025-10-01", "completion_date": "2026-01-05", "has_results": false, "last_update_posted_date": "2026-01-07", "last_synced_at": "2026-06-11T10:39:40.533Z", "location_count": 2, "location_summary": "Austin, Texas • Houston, Texas", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06555562" }, { "nct_id": "NCT01402661", "title": "CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [], "intervention_types": [], "sponsor": "CorEvitas", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 91758, "start_date": "2002-02", "completion_date": "2100-12", "has_results": false, "last_update_posted_date": "2025-10-02", "last_synced_at": "2026-06-11T10:39:40.533Z", "location_count": 1, "location_summary": "Waltham, Massachusetts", "locations": [ { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01402661" }, { "nct_id": "NCT04751396", "title": "Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ankylosing Spondylitis", "Autoimmune Disease", "Crohn Disease", "Enteropathic Arthritis", "Enteropathic Spondylitis", "Inflammatory Bowel Disease", "Melanoma", "Psoriasis", "Psoriatic Arthritis", "Reactive Arthritis", "Rheumatoid Arthritis", "Systemic Lupus Erythematosus", "Ulcerative Colitis" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2022-04-20", "completion_date": "2027-02-02", "has_results": false, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-06-11T10:39:40.533Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04751396" }, { "nct_id": "NCT07180537", "title": "Creating Health Course Study for People With Rheumatological Conditions", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rheumatoid Arthritis", "Sjogren's Syndrome", "Systemic Lupus Erythematosus", "Mixed Connective Tissue Disease", "Psoriatic Arthritis" ], "interventions": [ { "name": "Creating Health Online Course", "type": "BEHAVIORAL" }, { "name": "Delayed access to Creating Health Online Course", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Terry L. Wahls", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 200, "start_date": "2025-12-01", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-01-08", "last_synced_at": "2026-06-11T10:39:40.533Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT07180537" }, { "nct_id": "NCT04839315", "title": "COVID-19 Vaccination in Rheumatic Disease Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Systemic Lupus Erythematosus", "Sjogren's Syndrome", "Inflammatory Myositis", "Psoriatic Arthritis", "Gout", "Ankylosing Spondylitis", "Arthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis)", "Osteoarthritis" ], "interventions": [ { "name": "mRNA COVD19 vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2021-02-15", "completion_date": "2022-02-09", "has_results": false, "last_update_posted_date": "2022-06-03", "last_synced_at": "2026-06-11T10:39:40.533Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04839315" }, { "nct_id": "NCT03816345", "title": "Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autoimmune Disease", "Crohn Disease", "Dermatomyositis", "Hematopoietic and Lymphoid Cell Neoplasm", "Inflammatory Bowel Disease", "Malignant Solid Neoplasm", "Multiple Sclerosis", "Psoriasis", "Psoriatic Arthritis", "Rheumatoid Arthritis", "Sjogren Syndrome", "Systemic Lupus Erythematosus", "Systemic Scleroderma", "Ulcerative Colitis" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cabozantinib", "type": "DRUG" }, { "name": "Fluoropyrimidine", "type": "DRUG" }, { "name": "Ipilimumab", "type": "BIOLOGICAL" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Platinum Compound", "type": "DRUG" }, { "name": "Platinum Doublet", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2019-07-16", "completion_date": "2028-03-30", "has_results": false, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-06-11T10:39:40.533Z", "location_count": 51, "location_summary": "Birmingham, Alabama • Palo Alto, California • Sacramento, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03816345" } ] }